Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -47.54% is 22% above its 5-year average of -61.13%, around the middle of its 5-year range (-80.74%–9.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 240.47% below its 12-month average of -13.96%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -47.54%.
RETURN ON INVESTED CAPITAL (ROIC)
-47.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-13.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-42.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-61.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-240.47%
CURRENT VS 3Y AVG
-12.03%
CURRENT VS 5Y AVG
+22.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-33.31%
vs the sector median at left
Black Diamond Therapeutics, Inc.
Market Cap
$103.14M
Return on Invested Capital (ROIC)
-47.54%
TTM Avg
-13.96%
3Y Avg
-42.43%
5Y Avg
-61.13%
Market Cap
$102.75M
Return on Invested Capital (ROIC)
-82.35%
TTM Avg
-77.56%
3Y Avg
-62.72%
5Y Avg
-68.20%
Market Cap
$104.26M
Return on Invested Capital (ROIC)
41.64%
TTM Avg
-39.48%
3Y Avg
-25.23%
5Y Avg
-17.21%
Market Cap
$104.68M
Return on Invested Capital (ROIC)
-47.75%
TTM Avg
-127.40%
3Y Avg
-174.63%
5Y Avg
-174.63%
Market Cap
$101.36M
Return on Invested Capital (ROIC)
5.11%
TTM Avg
-4.38%
3Y Avg
-1.84%
5Y Avg
2.15%
Market Cap
$106.52M
Return on Invested Capital (ROIC)
-92.16%
TTM Avg
-430.04%
3Y Avg
-259.02%
5Y Avg
-188.28%
Market Cap
$99.62M
Return on Invested Capital (ROIC)
-35.98%
TTM Avg
-82.06%
3Y Avg
-144.65%
5Y Avg
-107.36%
Market Cap
$106.93M
Return on Invested Capital (ROIC)
-73.94%
TTM Avg
-76.71%
3Y Avg
-67.16%
5Y Avg
-152.71%
Market Cap
$106.96M
Return on Invested Capital (ROIC)
-352.19%
TTM Avg
-1462.52%
3Y Avg
-874.13%
5Y Avg
-711.22%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | $103.14M | -47.54% | -13.96% | -42.43% | -61.13% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | -82.35% | -77.56% | -62.72% | -68.20% |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 41.64% | -39.48% | -25.23% | -17.21% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | -47.75% | -127.40% | -174.63% | -174.63% |
| The Joint Corp. (JYNT)vs › | $101.36M | 5.11% | -4.38% | -1.84% | 2.15% |
| Immunic, Inc. (IMUX)vs › | $106.52M | -92.16% | -430.04% | -259.02% | -188.28% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | -35.98% | -82.06% | -144.65% | -107.36% |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | -73.94% | -76.71% | -67.16% | -152.71% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | -352.19% | -1462.52% | -874.13% | -711.22% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | -34.77% | -10.04% | -11.68% | -11.21% |
ROIC
-47.5%
ROE
-44.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -47.54% |
| 2026-03-31 | -43.60% |
| 2025-12-31 | 9.84% |
| 2025-09-30 | 8.34% |
| 2025-06-30 | 3.15% |
| 2025-03-31 | -2.51% |
| 2024-12-31 | -77.19% |
| 2024-09-30 | -69.48% |
| 2024-06-30 | -66.32% |
| 2024-03-31 | -67.75% |
| 2023-12-31 | -62.24% |
| 2023-09-30 | -55.59% |
| 2023-06-30 | -80.74% |
| 2023-03-31 | -72.28% |
| 2022-12-31 | -65.84% |
| 2022-09-30 | -60.94% |
| 2022-06-30 | -61.57% |
| 2022-03-31 | -60.92% |
| 2021-12-31 | -56.63% |
| 2021-09-30 | -50.04% |
| 2021-06-30 | -40.50% |
| 2021-03-31 | -29.67% |
| 2020-12-31 | -22.05% |
| 2020-09-30 | -16.93% |
| 2020-06-30 | -13.52% |
| 2020-03-31 | -10.79% |
| 2019-12-31 | -19.12% |
| 2019-09-30 | -28.96% |
| 2019-06-30 | -41.91% |
| 2018-12-31 | -18.08% |
